SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-022420
Filing Date
2019-04-30
Accepted
2019-04-30 16:50:34
Documents
4
Period of Report
2019-06-20
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv519828_def14a.htm DEF 14A 443265
2 GRAPHIC card01.jpg GRAPHIC 125691
3 GRAPHIC card02.jpg GRAPHIC 53696
4 GRAPHIC tv518276_img01.jpg GRAPHIC 20384
  Complete submission text file 0001144204-19-022420.txt   719938
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 19782644
SIC: 2836 Biological Products, (No Diagnostic Substances)